Literature DB >> 16290093

Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity.

Pärt Peterson1, Leena Peltonen.   

Abstract

Autoimmune polyendocrinopathy syndrome type 1 (APS1) is a monogenic autoimmune syndrome, which is caused by defect in AIRE gene on chromosome 21. Several autoimmune diseases occur in APS1 patients, often starting in first two decades of life. A gene defective in APS1, autoimmune regulator (AIRE), encodes nuclear protein involved in transcriptional processes. Recent findings in animal models indicate a critical role for AIRE in regulation of self-antigen expression in thymus. Identification of the AIRE gene, detailed characterization of molecular pathogenesis of human APS1 as well as analyses of mouse models carrying targeted interruption of Aire gene have provided new views on our understanding of molecular background of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16290093     DOI: 10.1016/j.jaut.2005.09.022

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  31 in total

1.  Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism.

Authors:  Jens Derbinski; Sheena Pinto; Stefanie Rösch; Klaus Hexel; Bruno Kyewski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-07       Impact factor: 11.205

Review 2.  Control of central and peripheral tolerance by Aire.

Authors:  Todd C Metzger; Mark S Anderson
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 3.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

Authors:  Kai Kisand; Pärt Peterson
Journal:  J Clin Immunol       Date:  2015-07-05       Impact factor: 8.317

4.  A history of pituitary pathology.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

5.  Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.

Authors:  Tomohiro Hori; Hidenori Ohnishi; Takahide Teramoto; Kohji Tsubouchi; Takafumi Naiki; Yoshinobu Hirose; Osamu Ohara; Mariko Seishima; Hideo Kaneko; Toshiyuki Fukao; Naomi Kondo
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

6.  A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

Authors:  Li Zhang; Jennifer M Barker; Sunanda Babu; Maureen Su; Matthew Stenerson; Mickie Cheng; Anthony Shum; Ehud Zamir; Raffaele Badolato; Adam Law; George S Eisenbarth; Mark S Anderson
Journal:  Clin Immunol       Date:  2007-09-06       Impact factor: 3.969

7.  Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1.

Authors:  Jason J Devoss; Anthony K Shum; Kellsey P A Johannes; Wen Lu; Anna K Krawisz; Peter Wang; Ting Yang; Norbert P Leclair; Cecilia Austin; Erich C Strauss; Mark S Anderson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Sicilian family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and lethal lung disease in one of the affected brothers.

Authors:  Filippo De Luca; Mariella Valenzise; Rita Alaggio; Teresa Arrigo; Giuseppe Crisafulli; Giuseppina Salzano; Sara Cervato; Barbara Mariniello; Francesca Lazzarotto; Corrado Betterle
Journal:  Eur J Pediatr       Date:  2008-02-15       Impact factor: 3.183

9.  Autoimmune regulator deficiency results in decreased expression of CCR4 and CCR7 ligands and in delayed migration of CD4+ thymocytes.

Authors:  Martti Laan; Kai Kisand; Vivian Kont; Kaidi Möll; Liina Tserel; Hamish S Scott; Pärt Peterson
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire.

Authors:  Maureen A Su; Karen Giang; Kristina Zumer; Huimin Jiang; Irena Oven; John L Rinn; Jason J Devoss; Kellsey P A Johannes; Wen Lu; James Gardner; Angela Chang; Paula Bubulya; Howard Y Chang; B Matija Peterlin; Mark S Anderson
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.